Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy

Alkeraithe, Fawaz; Hamri, Saeed Bin; Alsaleh, Faisal; Alasmari, Faisal A.

doi:10.1016/j.eucr.2022.102125

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, after Rezum, most adverse effects were temporary and non-serious, occurring in 0-76% of patients (median 29%) [ 5 ]. There has been one reported encapsulated hematoma after Rezum therapy, in which the patient went to the emergency department with hematuria and clot retention two months after Rezum [ 6 ].…”

Section: Discussionmentioning

confidence: 99%

Development of a Prostatic Urethral Cyst After Rezum Causing Persistent Lower Urinary Tract Symptoms

AlAmri,

Eid,

AlShehri

2023

Cureus

View full text Add to dashboard Cite

Water vapor thermal therapy (WVTT) is a new modality. There are just a few short periods of outcome surveillance following Rezum, with a maximum term of five years. The majority of side effects are irritative lower urinary tract symptoms caused by endoscopic manipulation and typically last a short time. Herein, we present a novel case of a 71-year-old male patient with a Rezum-induced prostatic urethral cystic lesion. Five months following Rezum, an ultrasound was performed to evaluate persistent lower urinary tract symptoms (LUTS) revealed the lesion. The patient preferred conservative management rather than cystoscopy and ablation of prostatic urethral cyst.

show abstract

Section: Discussionmentioning

confidence: 99%